Eurofins develops monkeypox PCR assay

By staff writers

June 23, 2022 -- Eurofins Technologies has developed a new multiplex real-time polymerase chain reaction (RT-PCR) assay for the detection of the monkeypox virus and its differentiation from other orthopoxviruses.

Available for research use only from the beginning of July, the assay uses a generic target for orthopoxviruses and a specific target for monkeypox, the company said.

The monkeypox virus belongs to the orthopoxvirus genus, which encompasses pathogenic viruses like smallpox, cowpox, and buffalopox, all of which exhibit similar symptoms in infected patients.

Eurofins raises 600M euros in public bond issue
Bioanalytical testing firm Eurofins Scientific on Tuesday announced it has raised 600 million euros ($632.1 million) in a senior, unsecured public bond...
Eurofins, Cornell team up for blood test on COVID damage
Eurofins Viracor recently entered into an exclusive license agreement with Cornell University to commercialize assays for clinically managing COVID-19...
Eurofins to conduct U.K. genotyping research program
Eurofins Genomics will genotype 5 million consenting participants in support of the Our Future Health program, a genotyping research program in the U.K.
Eurofins subsidiary launches at-home test for 'forever chemicals'
Eurofins Scientific subsidiary EmpowerDX has launched a new at-home blood test to detect and measure more than 40 per- and polyfluorinated alkyl substances...
Eurofins launches assay to detect omicron variant of COVID
Eurofins Technologies has launched a multiplex reverse transcription polymerase chain reaction assay that can detect the omicron variant of COVID-19.

Copyright © 2022

Last Updated mp 6/23/2022 12:39:59 PM

Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current